Basic Information
ID: ALA4825151
Type: Functional
Description: Antiviral activity against pseudovirus SARS-CoV-2 spike protein infected in HEK293 cells expressing ACE2 assessed as reduction in pseudotyped particle entry incubated for 48 hrs incubation by luminescence assay relative to control
Format: BAO_0000218
Organism: Severe acute respiratory syndrome coronavirus 2
Cell type: HEK293
Target: SARS-CoV-2(ALA4303835)
Document: ALA4823303
Antiviral activity against pseudovirus SARS-CoV-2 spike protein infected in HEK293 cells expressing ACE2 assessed as reduction in pseudotyped particle entry incubated for 48 hrs incubation by luminescence assay relative to control: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4825151
Efficacy
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 403.54 | 4.42 | 4.42 |
| 459.97 | 5.10 | 5.10 |
| 334.42 | 3.64 | 3.64 |
| 333.44 | 3.21 | 3.21 |
| 343.42 | 4.70 | 4.70 |
| 346.43 | 3.97 | 3.97 |
| 369.42 | 3.49 | 3.49 |
| 412.33 | 3.98 | 3.98 |
| 351.43 | 3.35 | 3.35 |
| 348.45 | 2.79 | 2.79 |
| 409.54 | 4.88 | 4.88 |
| 409.54 | 4.88 | 4.88 |